Organisation › Details

Bayer Pharma AG

https://www.bayer.com

	Start	2014-06-16 existent
	Group	Bayer (Group)
	Industry	pharmaceutical

	Region	Berlin
	Country	Germany
	Street	178 Müllerstr.
	City	13353 Berlin
		Address record changed: 2021-08-23

Basic data	Employees	n. a.


		Record changed: 2022-06-13

Picture [iito] Fighting Customers 650x100px

More documents for Bayer (Group)

[1] Bayer AG. (6/9/22). "Press Release: Bayer’s Vividion Emerging as Significant Player in San Diego Biotech Hub". Leverkusen & San Diego, CA....
[2] Bayer AG. (6/8/22). "Press Release: Bayer’s BlueRock Therapeutics Establishes European Site for Cell Therapy Innovation". Berlin....
[3] Bayer AG. (5/31/22). "Press Release: BlueRock Therapeutics Announces Completion of Enrollment of Phase 1 Trial in Patients with Parkinson’s Disease". Cambridge, MA....
[4] Atara Biotherapeutics, Inc.. (5/19/22). "Press Release: Atara Biotherapeutics Provides Update on Strategic Collaboration with Bayer". South San Francisco, CA....
[5] Bayer AG. (4/22/22). "Press Release: Bayer to Create Ag Biologicals Powerhouse Partnership with Ginkgo Bioworks, Advancing Joyn Bio Technology Platforms". Monheim....
[6] Bayer AG. (4/2122). "Press Release: Bayer Appoints Tara Frenkl as the New Head of Oncology Development at Its Oncology Strategic Business Unit". Berlin....
[7] Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin....
[8] Bayer AG. (4/1/22). "Press Release: Breakthrough Innovation Forum. Bayer Set to Drive Breakthrough Innovations in the Life Sciences". Leverkusen....
[9] Bayer AG. (3/31/22). "Press Release: Bayer to Strengthen Global Pharmaceuticals Production Network. Planned Investments of around €2bn over Next Three Years [Not intended for U.S. and UK Media]". Berlin....
[10] Bayer AG. (3/22/22). "Press Release: Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations". Tel Aviv....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]